Supplementary Tables S1-S4 from Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma

Kinase Inhibition Profile of ON123300 and PD0332991 (S1); Top 10 significantly enriched pathways for the 894 differentially regulated genes from NCI-H929 siRNA RNA sequencing analysis (S2); Top 10 significantly enriched pathways for the 180 differentially regulated genes between ON123300 and resistant cell lines (S3); Top 10 significantly downregulated pathways for the 180 differentially regulated genes between ON123300 and resistant cell lines (S4).